Condition: Healthy · Respiratory Disease · Chronic Renal Failure · Sponsor: Athens LifeTech Park
The aim of GENESIS clinical study is to map the HLA genomic region in the Greek population and evaluate possible correlations with selected underlying diseases.
This description comes directly from the study's public registry record.
Efi Giannopoulou · +306974784009 · egiannopoulou@lifetechpark.com
Always discuss trial participation with your own doctor first.
| 2nd Propaedeutic Department of Internal Medicine, Attikon University General Hospital | Chaïdári, Attica, Greece | Not Yet Recruiting |
| 2nd Department of Neurology, AHEPA University Hospital | Thessaloniki, Thessaloniki, Greece | Not Yet Recruiting |
| Department of Respiratory Medicine, University General Hospital of Alexandroupolis | Alexandroupoli, Thrace, Greece | Recruiting |
| Department of Infectious Diseases, 2nd Department of Internal Medicine, University General Hospital of Alexandroupolis | Alexandroupoli, Greece | Recruiting |
| Department of Cardiology, University General Hospital of Heraklion | Heraklion, Greece | Not Yet Recruiting |
| Department of Rheumatology, University Hospital of Heraklion | Heraklion, Greece | Not Yet Recruiting |
| Department of Respiratory, University Hospital of Ioannina | Ioannina, Greece | Recruiting |
| Department of Haematology, University General Hospital of Larissa | Larissa, Greece | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06227468